Cliff Belliveau and Phil Walls Featured in R&I Insights Email

The COVID-19 pandemic will continue to have an impact on workers’ compensation pharmacy for the foreseeable future. Recently, myMatrixx Vice President of Business Intelligence, Cliff Belliveau, joined Chief Clinical Officer, Phil Walls, to discuss this new landscape for industry publication Risk & Insurance’s Insights feature.
Learn more

New York Drug Formulary Notice of Delay

On May 24, 2021, the New York Workers’ Compensation Board (WCB) Chair delayed the implementation of amendments to the following regulations, which were scheduled to become effective on June 7, 2021...
Learn more